Delahaye, C.; Figarol, S.; Pradines, A.; Favre, G.; Mazieres, J.; Calvayrac, O.
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer. Cancers 2022, 14, 2613.
https://doi.org/10.3390/cancers14112613
AMA Style
Delahaye C, Figarol S, Pradines A, Favre G, Mazieres J, Calvayrac O.
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer. Cancers. 2022; 14(11):2613.
https://doi.org/10.3390/cancers14112613
Chicago/Turabian Style
Delahaye, Celia, Sarah Figarol, Anne Pradines, Gilles Favre, Julien Mazieres, and Olivier Calvayrac.
2022. "Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer" Cancers 14, no. 11: 2613.
https://doi.org/10.3390/cancers14112613
APA Style
Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazieres, J., & Calvayrac, O.
(2022). Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer. Cancers, 14(11), 2613.
https://doi.org/10.3390/cancers14112613